PO4-6: Serum levels of IGF-I and IGFBP-1 in Indian diabetic population (English)
- New search for: Tekle, M.
- New search for: Vasan, S.
- New search for: Brismar, K.
- New search for: Tekle, M.
- New search for: Vasan, S.
- New search for: Brismar, K.
In:
Abstracts of the Seventh International Congress of the GRS and the IGF Society, October 17-20 2014, Singapore
;
S50-S51
;
2014
-
ISSN:
- Article (Journal) / Print
-
Title:PO4-6: Serum levels of IGF-I and IGFBP-1 in Indian diabetic population
-
Contributors:
-
Published in:GROWTH HORMONE & IGF RESEARCH ; 24 ; S50-S51
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam
-
Publication date:2014-01-01
-
Size:S50-S51
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.4
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.4 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 24
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 2
-
Heat acclimation decreases the growth hormone response to acute constant-load exercise in the heatOopik, V. / Timpmann, S. / Kreegipuu, K. / Unt, E. / Tamm, M. et al. | 2014
- 10
-
Discordance of IGF-1 and GH stimulation testing for altered GH secretion in obesityStanley, T. L. / Feldpausch, M. N. / Murphy, C. A. / Grinspoon, S. K. / Makimura, H. et al. | 2014
- 16
-
Glucose homeostasis in adults with Prader-Willi syndrome during treatment with growth hormone: Results from a 12-month prospective studyJorgensen, A. P. / Ueland, T. / Sode-Carlsen, R. / Schreiner, T. / Rabben, K. F. / Farholt, S. / Hoybye, C. / Christiansen, J. S. / Bollerslev, J. et al. | 2014
- 22
-
Impact of the growth hormone replacement on bone status in growth hormone deficient adultsKuzma, M. / Kuzmova, Z. / Zelinkova, Z. / Killinger, Z. / Vanuga, P. / Lazurova, I. / Tomkova, S. / Payer, J. et al. | 2014
- 29
-
Increased genome instability and oxidative DNA damage and their association with IGF-1 levels in patients with active acromegalyBayram, F. / Bitgen, N. / Donmez-Altuntas, H. / Cakir, I. / Hamurcu, Z. / Sahin, F. / Simsek, Y. / Baskol, G. et al. | 2014
- 35
-
Effects of the regulation of follistatin mRNA expression by IGF-1 in duck (Anas platyrhynchos) skeletal muscleLiu, H. / Li, X. / Sun, L. / Wang, H. / Zhang, R. / Yang, C. / Li, L. / Wang, J. / He, H. / Krumm, C. et al. | 2014
- 42
-
Effects of thyroid hormone on the GH signal transduction pathwayOcaranza, P. / Lammoglia, J. J. / Iniguez, G. / Roman, R. / Cassorla, F. et al. | 2014
- 47
-
Extrapituitary growth hormone synthesis in humansPerez-Ibave, D. C. / Rodriguez-Sanchez, I. P. / Garza-Rodriguez, M. d. L. / Barrera-Saldana, H. A. et al. | 2014
- 54
-
Effect of milk proteins on linear growth and IGF variables in overweight adolescentsLarnkjaer, A. / Arnberg, K. / Michaelsen, K. F. / Jensen, S. M. / Molgaard, C. et al. | 2014
- 60
-
Administration of growth hormone and nandrolone decanoate alters mRNA expression of the GABA"B receptor subunits as well as of the GH receptor, IGF-1, and IGF-2 in rat brainGronbladh, A. / Johansson, J. / Nyberg, F. / Hallberg, M. et al. | 2014
- 67
-
GLP-1 infusion reduces IGFBP-1 serum level in humansSkov, J. / Frystyk, J. / Christiansen, J. S. et al. | 2014
- 71
-
Non-functioning pituitary macroadenomas: Benefit from early growth hormone substitution after surgerySauer, N. / Flitsch, J. / Doeing, I. / Dannheim, V. / Burkhardt, T. / Aberle, J. et al. | 2014
- 76
-
Insulin-like growth factor-1 (IGF-1) enhances developmental competence of cat embryos cultured singly by modulating the expression of its receptor (IGF-1R) and reducing developmental blockThongkittidilok, C. / Tharasanit, T. / Sananmuang, T. / Buarpung, S. / Techakumphu, M. et al. | 2014
- 83
-
Radiometrical, hormonal and biological correlates of skeletal growth in the female rat from birth to senescencedel Pozo, E. / Janner, M. / Mackenzie, A. R. / Arampatzis, S. / Dixon, A. K. / Perrelet, R. / Ruch, W. / Lippuner, K. / Zapf, J. / Lamberts, S. W. et al. | 2014
- 89
-
Exogenous IGF-1 promotes hair growth by stimulating cell proliferation and down regulating TGF-@b1 in C57BL/6 mice in vivoLi, J. / Yang, Z. / Li, Z. / Gu, L. / Wang, Y. / Sung, C. et al. | 2014
- 95
-
The influence of age and exercise modality on growth hormone bioactivity in womenGordon, S. E. / Kraemer, W. J. / Looney, D. P. / Flanagan, S. D. / Comstock, B. A. / Hymer, W. C. et al. | 2014
- 104
-
Corrigendum to ''Metabolic alterations in patients who develop traumatic brain injury (TBI)-induced hypopituitarism'' [Growth Horm. IGF Res. 23 (4) (2013) 109-113]Prodam, F. / Gasco, V. / Caputo, M. / Zavattaro, M. / Pagano, L. / Marzullo, P. / Belcastro, S. / Busti, A. / Perino, C. / Grottoli, S. et al. | 2014
- 105
-
Association between growth hormone therapy and mortality, cancer and cardiovascular risk: Systematic review and meta-analysisDeodati, A. / Ferroli, B. B. / Cianfarani, S. et al. | 2014
- 112
-
Transcriptional and epigenetic control of IGF1R gene expression: Implications in metabolism and cancerWerner, H. / Sarfstein, R. et al. | 2014
- 119
-
Effects of levothyroxine on growth hormone (gh) sensitivity in children with idiopathic short statureGarcia, R. J. / Iniguez, G. / Gaete, X. / Linares, J. / Ocaranza, P. / Avila, A. / Roman, R. / Cassorla, F. et al. | 2014
- 123
-
The growth hormone receptor exon 3 polymorphism is not associated with height or metabolic traits in healthy young adultsMartins, C. S. / Fernandes-Rosa, F. L. / Espineira, A. R. / de Souza, R. M. / de Castro, M. / Barbieri, M. A. / Bettiol, H. / Jorge, A. L. / Antonini, S. R. et al. | 2014
- 130
-
Investigation of IGF2, Hedgehog and fusion gene expression profiles in pediatric sarcomasde Souza, R. R. / Oliveira, I. D. / del Giudice Paniago, M. / Yaoita, F. H. K. / Caran, E. M. M. / Macedo, C. R. P. D. / Petrilli, A. S. / Abib, S. d. C. V. / de Seixas Alves, M. T. / de Toledo, S. R. C. et al. | 2014
- 137
-
Expression levels of insulin-like growth factors 1 and 2 in head and neck squamous cell carcinomaZhi, X. / Lamperska, K. / Golusinski, P. / Schork, N. J. / Luczewski, L. / Golusinski, W. / Masternak, M. M. et al. | 2014
- 142
-
Circulating IGF-axis protein levels and their relation with levels of plasma adipocytokines and macronutrient consumption in womenBeasley, J. M. / Wedick, N. M. / Rajpathak, S. N. / Xue, X. / Holmes, M. D. / Gunter, M. J. / Wylie-Rosett, J. / Rohan, T. E. / Pollak, M. / Kaplan, R. C. et al. | 2014
- 150
-
Corneal thickness in children with growth hormone deficiency: The effect of GH treatmentCiresi, A. / Morreale, R. / Radellini, S. / Cillino, S. / Giordano, C. et al. | 2014
- 155
-
In memory of Francesco Maria MinutoFerone, D. / Boschetti, M. / Arvigo, M. / Fazzuoli, L. / Giusti, M. / del Monte, P. et al. | 2014
- 157
-
Optimizing IGF-I for skeletal muscle therapeuticsPhilippou, A. / Barton, E. R. et al. | 2014
- 164
-
IGFBP-3: A cell fate pivot in cancer and diseaseJohnson, M. A. / Firth, S. M. et al. | 2014
- 174
-
Long-term effects of growth hormone replacement therapy on liver function in adult patients with growth hormone deficiencyMatsumoto, R. / Fukuoka, H. / Iguchi, G. / Nishizawa, H. / Bando, H. / Suda, K. / Takahashi, M. / Takahashi, Y. et al. | 2014
- 180
-
Autosomal recessive form of isolated growth hormone deficiency is more frequent than the autosomal dominant form in a Brazilian cohortLido, A. C. V. / Franca, M. M. / Correa, F. A. / Otto, A. P. / Carvalho, L. R. / Quedas, E. P. S. / Nishi, M. Y. / Mendonca, B. B. / Arnhold, I. J. P. / Jorge, A. A. L. et al. | 2014
- 187
-
IGF-I sensitivity in Silver-Russell syndrome with IGF2/H19 hypomethylationIliev, D. I. / Kannenberg, K. / Weber, K. / Binder, G. et al. | 2014
- 192
-
Behavioural phenotyping of male growth hormone-releasing hormone (GHRH) knockout miceLeone, S. / Shohreh, R. / Manippa, F. / Recinella, L. / Ferrante, C. / Orlando, G. / Salvatori, R. / Vacca, M. / Brunetti, L. et al. | 2014
- 198
-
Impact of moderate interval exercise versus supine rest on the pharmacokinetics and pharmacodynamic profiles of subcutaneously administered growth hormone in adult growth hormone deficient patientsJanukonyte, J. / Parkner, T. / Lauritzen, T. / Christiansen, J. S. / Frystyk, J. / Pedersen, H. S. / Laursen, T. et al. | 2014
- 205
-
hGH isoform differential immunoassays applied to blood samples from athletes: Decision limits for anti-doping testingHanley, J. A. / Saarela, O. / Stephens, D. A. / Thalabard, J. C. et al. | 2014
- 216
-
Circulating asymmetric dimethylarginine and lipid profile in pre-pubertal children with growth hormone deficiency: Effect of 12-month growth hormone replacement therapyDe Marco, S. / Marcovecchio, M. L. / Caniglia, D. / De Leonibus, C. / Chiarelli, F. / Mohn, A. et al. | 2014
- S1
-
SY1-4: Dosing and monitoring GH treatment in Turner syndromeTanaka, T. et al. | 2014
- S2
-
SY2-1: Insulin-like growth factor 2 mRNA binding proteins (IMP/IGF2BP) as mRNA safe houses in cancer and developmentChristiansen, J. / Jonson, L. / Vikesaa, J. / Hansen, T. v. O. / Nielsen, F. C. et al. | 2014
- S3
-
SY2-5: The G protein estrogen receptor (GPER) is involved in IGF-I/insulin signaling in cancer cellsMaggiolini, M. et al. | 2014
- S5
-
OR1-3: The molecular mechanism of dominantly inherited short stature caused by GH polymersWu, Z. / Junnila, R. / Strasburger, C. J. et al. | 2014
- S6
-
OR1-6: Combination medical therapy for acromegaly: the ACROSTUDY experienceStrasburger, C. / Hey-Hadavi, J. / Akerblad, A. C. / Mattsson, A. F. / Koltowska-Haggstrom, M. / Biller, B. M. K. et al. | 2014
- S7
-
OR2-2: The mitochondrial peptide humanin has fasting mimetic activity leading to suppression of circulating IGF-I and increases in IGFBP-1 levelsXiao, J. / Wan, J. / Mehta, H. / Lue, Y. H. / Jia, Y. / Swerdloff, R. / Wang, C. / Cohen, P. et al. | 2014
- S9
-
OR3-1: Spatial learning, memory and signaling cross-talk: genomic and behavioral analysis in wild type versus GH modified (bGH & GHA) miceBasu, A. / Kopchick, J. J. et al. | 2014
- S10
-
OR3-4: GH activated signal transducer and activator of transcription 5 is required for induction of beige fat in inguinal white adipose tissueNelson, C. N. / Ieremia, M. / Constantin, L. / List, E. O. / Kopchick, J. J. / Waters, M. J. et al. | 2014
- S12
-
OR4-3: Safety and effectiveness of Increlex(R) therapy in children enrolled in the Increlex Growth Forum Database (IGFD) in Europe: 4-year interim resultsBang, P. / Polak, M. / Woelfle, J. / Sicsic, A. / Lecanuet, S. et al. | 2014
- S13
-
OR4-6: The expression of insulin-like growth factor type 1 receptor (IGF1R) is increased in obese childrenRicco, R. C. / Custodio, R. J. / Atique, P. V. / Liberatore, R. D. / Ricco, R. G. / Martinelli, C. E. et al. | 2014
- S14
-
OR5-3: A GH antagonist fusion with GH binding protein is biologically active, shows delayed clearance and inhibits growth in a rabbit modelWilkinson, I. / Pradhananga, S. / Sayers, J. / Artymiuk, P. / Phipps, M. / Ross, R. et al. | 2014
- S15
-
OR5-6: Amplified stem/progenitor cells in a mouse model of prostate tumorigenesis induced by autocrine prolactinSackmann Sala, L. / Mosquera-Garrote, N. / Chiche, A. / Pourmir, I. / Boutillon, F. / Goffin, V. et al. | 2014
- S17
-
OR6-6: Dermal fibroblast secreted IGF-I protects skin keratinocytes against ultraviolet B radiation induced damageFernandez, T. L. / Van Lonkhuyzen, D. R. / Dawson, R. / Kimlin, M. / Upton, Z. et al. | 2014
- S18
-
OR7-3: Safety and efficacy results of a 6 month, randomized, multicenter trial of a novel long-acting rhGH (VRS-317) in naive to treatment, pre-pubertal children with GH deficiencyBright, G. M. / Moore, W. V. / Nguyen, H. Q. / Kletter, G. B. / Miller, B. S. / Van Meter, Q. / Humphriss, E. / Cleland, J. L. et al. | 2014
- S20
-
OR7-7: Pasireotide LAR provides superior efficacy over octreotide LAR and lanreotide ATG in patients with inadequately controlled acromegaly: a phase III, multicenter, randomized study (PAOLA)Fleseriu, M. / Gadelha, M. / Bronstein, M. D. / Brue, T. / Coculescu, M. / Guitelman, M. / Pronin, V. / Raverot, G. / Shimon, I. / Fleck, J. et al. | 2014
- S21
-
OR8-2: Insulin-like growth factor receptor inhibition in mammary epithelium enhances Wnt1- mediated tumors, canonical Wnt signaling and IGF-II/insulin-receptor A expressionWood, T. L. / Rota, L. M. / Albanito, L. / Shin, M. E. / Goyeneche, C. L. / Shushanov, S. / Gallagher, E. J. / Leroith, D. / Lazzarino, D. A. et al. | 2014
- S22
-
OR8-5: Novel mechanisms by which Nedd4-IRS-2 complexes enhance IGF-I signals, and their roles in IGF-I action in prostate cancer cell proliferationFukushima, T. / Yoshihara, H. / Furuta, H. / Hakuno, F. / Saeki, Y. / Nakatsu, Y. / Kamata, H. / Asano, T. / Takahashi, S. I. et al. | 2014
- S23
-
OR8-8: Serum IGF-I measured longitudinally during pre-school years - relation to gender, body size, and nutrition such as essential fatty acids and vitamin DDahlgren, J. et al. | 2014
- S26
-
PO1-5: Socs 2 plays no major role in the increased expression of fibrotic genes in the remnant kidneyAssadi, M. H. / Abu Hilal, R. / Landau, D. / Chen, Y. / Medrano, J. / Rabkin, R. / Segev, Y. et al. | 2014
- S27
-
GP2-3: The role of the insulin receptor in breast cancer progressionRostoker, R. / Abelson, S. / Bitton-Worms, K. / Genkin, I. / Ben-Shmuel, S. / Caspi, A. / Tzukerman, M. / LeRoith, D. et al. | 2014
- S28
-
GP2-6: Differential effects of IGFBP-6 on migration of two ovarian cancer cell linesBach, L. / Yang, Z. et al. | 2014
- S29
-
GP4-7: ProIGF-II not matureIGF-II promotes estrogen independent breast cancer growth and metastasis in a SCID and Nude mouse model: differential signallng mechanisms thru IGF and Insulin receptors and phosphorylation/activation of estrogen and progesterone receptorsJian, T. / Kalla-Singh, S. / Radhakrishnan, V. K. / De Leon, M. A. / DeLeon, D. et al. | 2014
- S30
-
PO3-3: The hepatic expression of GHR and SOCS2 mRNA is increased before ovulation during the follicular phase in dairy cattleMense, K. / Meyerholz, M. / Knaack, H. / Lietzau, M. / Engelke, J. / Hoedemarker, M. / Piechotta, M. et al. | 2014
- S35
-
PO3-19: IGF-1 receptor C terminal tail phosphorylation on Y1250 in cancer cellsO Shea, S. P. / Fernandez, I. / Kelly, G. M. / O' Connor, R. et al. | 2014
- S37
-
GP3-2: Rosiglitazone treatment: acromegaly patients do not differ from normal type 2 diabetics in their IGFBP-1 and Insulin dynamics with euglycemic glucose clampTint, M. T. / Khoo, C. M. / Cunanan, E. / Liew, S. / Lee, K. O. et al. | 2014
- S41
-
PO2-9: Growth without growth hormoneRochmah, N. / Faizi, M. et al. | 2014
- S42
-
PO2-12: Development and characterization of manufacturing process of MOD-4023, a long acting human growth hormon to support clinical and commercial supplyHershkovitz, O. / Moschovich, L. / Yana Felikman, Y. / Guy, R. / Fima, E. et al. | 2014
- S44
-
PO2-19: Growth hormone therapy in a child with Kearns Sayre syndrome and chronic kidney diseaseSng, A. / Loke, K. Y. / Lim, Y. / Ho, C. et al. | 2014
- S47
-
GP4-2: Effects of heparin administration on the generation of IGFBP-4 fragments during PCI treatment of ST-elevation myocardial infarction patientsHjortebjerg, R. / Lindberg, S. / Jensen, J. S. / Oxvig, C. / Bjerre, M. / Frystyk, J. et al. | 2014
- S48
-
GP4-5: Circulating levels of insulin-like growth factor-1(IGF-I)/insulin-like growth factor binding protein-3 (IGFBP-3) in obese patients: the state of type 2 diabetesKim, M. S. / Kim, S. Y. / Lee, D. Y. et al. | 2014
- S49
-
PO4-2: Variations in growth in relation to IGF-I levels in children born very preterm and target height influences from birth to 3-years of ageKistner, A. / Hellgren, G. / Niklasson, A. / Sigurdsson, J. / Lofqvist, C. / Hellstrom, A. et al. | 2014
- S50
-
PO4-6: Serum levels of IGF-I and IGFBP-1 in Indian diabetic populationTekle, M. / Vasan, S. / Brismar, K. et al. | 2014
- S51
-
PO4-9: Complex tissue-specific epigenotypes in Russell Silver syndrome with 11p15 ICR1 hypomethylation: major consequences for the diagnosisAzzi, S. / Blaise, A. / Steunou, V. / Thibaud, N. / Le Bouc, Y. / Netchine, I. et al. | 2014
-
OR1-2: Impairment of anaerobic capacity in adults with growth hormone deficiencyChikani, V. / Cuneo, R. / Hickman, I. / Ho, K. et al. | 2014
-
OR7-4: A phase 2, six-month dose-response study to investigate TransCon hGH, a long-acting hGH, in treatment naive children with idiopathic growth hormone deficiency (IGHD)Chatelain, P. / Malievsky, O. / Radziuk, K. / Elsedfy, H. / Mikhailova, E. / Beckert, M. et al. | 2014
-
OR8-1: Insulin receptor substrate (IRS)-1 interacts with protein arginine methyltransferase 5 (PRMT5), emerging as a novel regulator of alternative pre-mRNA splicingOzoe, A. / Narita, Y. / Fukushima, T. / Kataoka, N. / Ito, A. / Yoshida, M. / Chida, K. / Asano, T. / Hakuno, F. / Takahashi, S. I. et al. | 2014
-
OR8-4: A novel antisense long noncoding RNA within the IGF1R gene locus is imprinted in hematopoietic malignanciesSun, J. / Li, W. / Sun, Y. / Wang, H. / Cui, J. / Wang, G. / Wei, Z. / Hoffman, A. / Hu, J. et al. | 2014
-
GP2-2: The deubiquitinating enzyme, USP9X positively regulates insulin-like growth factor (IGF)-dependent cell growth by inhibition of degradation of IGF-I receptor (IGF-IR) and insulin receptor substrate (IRS)-2 in prostate cancer cellsFuruta, H. / Yoshihara, H. / Fukushima, T. / Saeki, Y. S. / Ito, A. / Worrall, C. / Girnita, L. / Tanaka, K. / Yoshida, M. / Asano, T. et al. | 2014
-
GP4-1: Loss of PI 3-kinase-binding protein PI3KAP/XB130 suppresses thyroid function and induces enlargement of thyroid glands in miceYamanaka, D. / Hakuno, F. / Minami, S. / Hashimoto, K. / Suzuki, K. / Chida, K. / Takahashi, S. I. et al. | 2014
-
PO3-13: ADLib(R) system: a versatile antibody discovery platformHashimoto, S. / Uchiki, T. / Moriyama, S. / Sasakura, Y. / Tsuji, T. / Konakahara, S. / Nakazaki, Y. / Hani, T. / Asagoshi, K. / Sawada, A. et al. | 2014
-
GP3-5: Thyroid hormone activation regulates exercise induced growth hormone releaseIgnacio, D. L. / Silvestre, D. H. S. / Cavalcanti-de-Albuquerque, J. P. / Neto, R. A. L. / Ferreira, A. C. C. / Carvalho, D. P. / Werneck-de-Castro, J. P. S. et al. | 2014
-
PO2-2: An evaluation of the safety and usability of FlexPro(R) 30 mg/3 mL, for the delivery of Norditropin(R) in patients requiring growth hormone (GH) therapyKappelgaard, A. M. / Wen, Y. / Klinck, R. / Qvist, M. / Fuchs, G. S. et al. | 2014
-
PO2-8: Specific measurement of human growth hormone oligomers in blood and its possible clinical applicationWu, Z. / Strasburger, C. J. et al. | 2014
-
PO2-14: Genetic markers of insulin resistance are associated with growth hormone response in short SGA children - the North European SGA study (NESGAS)Jensen, R. B. / Thankamony, A. / Day, F. / Kirk, J. / Donaldson, M. / Ivarsson, S. A. / Soder, O. / Roche, E. / Hoey, H. / Juul, A. et al. | 2014
-
PO2-24: Elevated spontaneous trough GH levels are associated with Lipoprotein (a) in short prepubertal children with high waist-hip ratioDecker, R. / Andersson, B. / Kristrom, B. / Nygren, A. / Albertsson-Wikland, K. et al. | 2014
-
GP4-3: Epigenetic analyses of the insulin-like growth factor binding protein 1 gene in diabetes and diabetic nephropathyGu, T. / Gu, H. F. / Falhammar, H. / Hilding, A. / Sjoholm, L. K. / Ostenson, C. G. / Ekstrom, T. J. / Brismar, K. et al. | 2014
-
SY2-4: IGFBP-2 in Cancer: From The Matrix to The Inside JobRusso, V. C. et al. | 2014
-
OR4-1: Randomised controlled clinical trial contrasting current GH doses with dose based on IGF-I titration in children born small for gestational age (NESGAS)Jensen, R. B. / Thankamony, A. / O'Connell, S. M. / Kirk, J. / Donaldson, M. / Ivarsson, S. A. / Soder, O. / Roche, E. / Hoey, H. / Dunger, D. B. et al. | 2014
-
OR5-4: The choice of growth hormone receptor signalling pathway determines longevityChhabra, Y. / Nelson, C. N. / Plescher, M. / Brooks, T. / Waters, M. J. et al. | 2014
-
OR6-2: IRS-1 promotes embryonic growth of zebrafish through IGF-IR signal-dependent and -independent mechanisms in response to developmental stages and environmental oxygen availabilityKamei, H. / Sawada, R. / Yoneyama, Y. / Hakuno, F. / Shimizu, T. / Takahashi, S. I. et al. | 2014
-
OR6-4: Sustained IGF-II production is necessary for adult neurogenesisZiegler, A. N. / Testai, J. / Constancia, M. / Sandovici, I. / Wood, T. L. / Levison, S. W. et al. | 2014
-
OR7-1: A reversible albumin-binding GH derivative possesses a promising once-weekly treatment profile and is well tolerated in adult subjects with growth hormone deficiencyHojby Rasmussen, M. / Janukonyte, J. / Klose, M. / Marina, D. / Tanvig, M. / Nielsen, L. F. / Hoybye, C. / Andersen, M. / Feldt-Rasmussen, U. / Sandahl Christiansen, J. et al. | 2014
-
OR7-2: The MOD-4023 story; a long acting GH from proof of concepts in animal models to growth hormone deficient populations clinical studies (adults and pediatric )Hart, G. / Hershkovitz, O. / Koren, R. / Amitzi, L. / Fima, E. et al. | 2014
-
OR7-8: A phase II randomised, open-label, parallelgroup study of the safety, tolerability, pharmacokinetics and efficacy of two subcutaneous dosing regimens of ATL1103 in adult patients with acromegalyTrainer, P. J. / Newell-Price, J. / Ayuk, J. / Aylwin, S. / Drake, W. M. / Rees, A. / Chanson, P. / Brue, T. / Webb, S. M. / Fajardo, C. et al. | 2014
-
GP2-7: The IGF/IGFR pathway regulates axial patterning during early neural development in mammalTakata, N. / Sakakura, E. / Kasukawa, T. / Eiraku, M. / Sasai, Y. et al. | 2014
-
GP3-4: Discordance of post-surgical nadir GH during OGTT and serum IGF-I levels in patients with acromegalyFukuda, I. / Hizuka, N. / Muraoka, T. / Amano, K. / Kawamata, T. / Okada, Y. / Ichihara, A. et al. | 2014
-
PO2-1: The pathogenesis of anti-PIT-1 antibody syndrome - the involvement of PIT-1-reactive cytotoxic T lymphocytesBando, H. / Iguchi, G. / Fukuoka, H. / Matsumoto, R. / Suda, K. / Nishizawa, H. / Takahashi, M. / Tojo, K. / Takahashi, Y. et al. | 2014
-
PO2-3: Multiple doses of a reversible albumin-binding growth hormone derivative demonstrate no differences in PK and PD between Japanese and non-Asian subjectsHojby Rasmussen, M. / Olsen, M. W. B. / Alifrangis, L. / Klim, S. / Suntum, M. et al. | 2014
-
PO2-5: Severe headache relieved by short-acting somatostatin analogue in a patient with Acromegaly resistant to longacting somatostatin analoguesHoybye, C. et al. | 2014
-
PO2-16: IGF-1 as nutritional markerKim, J. H. / Lee, J. et al. | 2014
-
PO4-3: Serum levels of insulin-like growth factor I (IGF-I) and insulin-like growth factor binding protein 3 (IGFBP-3) in women with cervical cancerCho, D. H. / Kim, M. S. et al. | 2014
-
OR3-3: Liver-specific (LiGHRKO) and fat-specific (FaGHRKO) growth hormone receptor gene disrupted mice demonstrate paradoxical longevity and provide evidence for GH stimulated liver/adipose tissue-crosstalkList, E. O. / Berryman, D. E. / Jara, A. / Ikeno, Y. / Miller, R. A. / Kopchick, J. J. et al. | 2014
-
OR3-5: NPY neurons as a critical hypothalamic node for the control of GH release relative to food intakeHuang, L. / Tan, H. / Fogarty, M. / Stark, R. / Andrews, Z. / Veldhuis, J. / Herzog, H. / Chen, C. / Steyn, F. et al. | 2014
-
OR4-4: The causal role of IGFs and IGFBPs in prostate cancer: a Mendelian randomization studyBonilla, C. / Rowlands, M. A. / Lewis, S. J. / Palmer, T. / Gaunt, T. R. / Davey Smith, G. / Gunnell, D. / Donovan, J. L. / Hamdy, F. C. / Neal, D. E. et al. | 2014
-
OR6-3: Early postnatal nutritional programming of growth involves GHRH neurons axon growth stimulation by leptin & IGF-IDecourtye, L. / Mire, E. / Clemessy, M. / Heurtier, V. / Godefroy, D. / Cong, R. / Ledent, T. / Robinson, I. / Reaux-Le Goazigo, A. / Mollard, P. et al. | 2014
-
OR8-3: Role of deubiquitinase USP7 in signalling through IGF-1RWorrall, C. / Suleymanova, N. / Yoshihara, H. / Hakuno, F. / Takahashi, S. I. / Girnita, A. / Girnita, L. et al. | 2014
-
PO3-2: Modulation of IGFBP1 protein expression by metforminAnsurudeen, I. / Brismar, K. et al. | 2014
-
PO3-12: Balancing the IGF-1R-Mdm2-p53 axis as novel therapeutic strategy in skin melanomaGirnita, A. / Worall, C. / Candrea, E. / Takahashi, S. I. / Girnita, L. et al. | 2014
-
PO3-15: Regulation of IGF-1 at the transcription level by IGFBP-1Ansurudeen, I. / Brismar, K. et al. | 2014
-
GP1-4: Mortality in patients with non-functioning pituitary adenoma with and without growth hormone replacement therapy. A case-controlled study in more than 400 patientsTrimpou, P. / Johannsson, G. / Andersson, E. / Nilsson, A. G. / Olsson, D. S. et al. | 2014
-
PO2-11: Evidence for truncated somatostatin receptor 5 modulation of therapy response to somatostatin analogues in two patients with acromegaly and severe headacheMarina, D. / Burman, P. / Klose, M. / Casar-Borota, O. / Luque, R. M. / Castano, J. P. / Feldt-Rasmussen, U. et al. | 2014
-
OR2-5: Linkage of reproductive development, fat metabolism and lifespan by the RGD-motif of IGFBP-2 in female transgenic miceHoeflich, A. / Spitschak, M. / Ohde, D. / Schindler, N. / Brenmoehl, J. / Langhammer, M. / Bielohuby, M. / Renner-Muller, I. / Wanke, R. / Metzger, F. et al. | 2014
-
OR3-6: Loss of acyl-ghrelin signalling in male ghrelin-O-acyltransferase knock-out mice results in reduced pulsatile growth hormone secretion and a derangement of GH pulse patternXie, T. Y. / Ngo, S. T. / Veldhuis, J. D. / Jeffery, P. L. / Chopin, L. K. / Tschop, M. / Trolle, V. / Epelbaum, J. / Steyn, F. J. / Chen, C. et al. | 2014
-
OR8-6: The anti-IGF signaling agents increase the efficacy of Trabectedin in Ewing sarcomaGarofalo, C. / Amaral, A. T. / Uboldi, S. / Mancarella, C. / Frapolli, R. / Manara, M. C. / Ordonez, J. L. / Belfiore, A. / Picci, P. / Hassan, B. et al. | 2014
-
PO1-1: Analysis of chimeric mice using growth hormone receptor gene disrupted (GHRKO) derived bone-marrow to investigate the role of GH signaling in the infiltration of proinflammatory macrophages in adipose tissueHerpy, J. / Okada, S. / Benencia, F. / Kopchick, J. J. et al. | 2014
-
PO3-4: IGF-1-regulated PDLIM2 protein is required for epithelial to mesenchymal transition (EMT) and transcription factor stabilityCox, O. T. / Bowe, R. A. / Tresse, E. / O'Connor, R. et al. | 2014
-
PO3-11: Porphyra yezoensis peptide stimulates the proliferation of IEC-6 cells by activating the insulin-like growth factor-I receptor signaling pathwayNam, T. J. / Lee, M. K. / Kim, I. H. / Choi, Y. H. et al. | 2014
-
PO3-17: Hypermethylation and hypomethylation of IGF-II DMRO (Insulin like growth factors-II Differentially Methylated Region) correlated to increased or decreased expression of IGF-II in breast cancer cells and paired breast tissues of African American and Caucasian breast cancer patientsRadhakrishnan, V. K. / De Leon, M. A. / DeLeon, D. et al. | 2014
-
GP1-6: Metabolic requirements to sustain NEFA and glucose homeostasis overrides the role of growth hormone in promoting rapid linear growth in hyperphagic MC4RKO miceTan, H. Y. / Huang, L. / Veldhuis, J. D. / Cowley, M. / Steyn, F. J. / Chen, C. et al. | 2014
-
PO2-6: Autocrine human growth hormone (hGH) promotes metabolic reprogramming in breast cancer cells to adapt to available glucoseBanerjee, A. / Pandey, V. K. / Lau, A. Y. C. / Lobie, P. E. et al. | 2014
-
PO2-26: Pharmacokinetic (PK) and pharmacodynamic (PD) modeling of MOD-4023 (a long-acting hGH-CTP) in adults and growth hormone (GH)-deficient childrenFisher, D. / Koren, R. / Amitzi, L. / Hershkovitz, O. / Hart, G. et al. | 2014
-
GP4-6: Effects of GH/IGF-I axis on retinal vascular morphology: retinal vascular morphology in Laron syndromeSekeroglu, H. T. / Kadayifcilar, S. / Kasim, B. / Arslan, U. / Ozon, Z. A. et al. | 2014
-
OR2-6: Cyclic glycine-proline is a regulator that dynamically controls IGF-1 homeostasis through altering IGF-1 binding to IGFBP3Guan, J. / Gluckman, P. / Yang, P. / Wen, J. / Krissansen, G. / Sun, K. / Zhou, Y. / McMahon, C. / Shorten, P. / Wake, G. et al. | 2014
-
OR5-1: Mechanism of activation of JAK2 by growth hormoneWaters, M. J. / Brooks, A. J. et al. | 2014
-
OR7-6: Safety and efficacy of ARX201: six month dose-ranging study of a novel long-acting pegylated growth hormone in young adults with growth hormone deficiencyRacz, K. / Coculescu, M. / Olyinik, V. / Popa, M. / Popovic, V. / Radiuk, K. / Senatorova, A. S. / Vlasenko, M. V. / Norman, T. / Juhasz, M. et al. | 2014
-
PO3-14: Activated STAT3 as a possible resistance mechanism to the anti-tumour effects of an anti-IGF-II neutralising antibody in hepatocellular carcinomaGreenall, S. A. / Johns, T. G. / Adams, T. E. et al. | 2014
-
PO2-15: Insulin tolerance test and GHRH plus arginine in the reassessment of pituitary function at adult height achievementDi Iorgi, N. / Salerno, M. C. / Cappa, M. / Loche, S. / Radetti, G. / Capaldo, D. / Allegri, A. / Napoli, F. / Calcagno, A. / Iovovich, O. B. et al. | 2014
-
GP4-4: SGA short stature bearing with a novel nonsense mutation (p.W1219X) in the IGF1R geneFujimoto, M. / Kawashima, Y. / Hamajima, T. / Miyahara, N. / Nishimura, R. / Hanaki, K. / Kanzaki, S. et al. | 2014
-
PO4-5: Insulin like growth factor-1 therapy in five patients with growth hormone insensitivityErsoy, B. / Ozhan, B. / Kizilay, D. / Kiremitci, S. et al. | 2014
-
PO4-7: Functional selectivity of the insulin-like growth factor type 1 receptor (IGF-1R) signaling: therapeutic implications for cancer treatmentGirnita, L. / Crudden, C. J. / Suleymanova, N. / Oprea, I. / Worrall, C. / Girnita, A. et al. | 2014
-
PO5-2: Serum prolactin level in chronic kidney diseaseVasilkova, O. / Szhmailik, M. / Zekenova, K. / Mokhort, T. et al. | 2014
-
SY1-7: Abuse of growth hormoneStrasburger, C. J. et al. | 2014
-
OR2-4: Exogenous administration of protease-resistant, non matrixbinding IGFBP-2 inhibits tumour growth in a murine model of breast cancerSoh, C. L. / McNeil, K. / Owczarek, C. M. / Hardy, M. / Fabri, L. J. / Pearse, M. / Delaine, C. A. / Forbes, B. E. et al. | 2014
-
PO3-9: Effects of endurance training on somatic growth in a rat model of chronic kidney disease (CKD)Troib, A. / Guterman, M. / Landau, D. / Rabkin, R. / Segev, Y. et al. | 2014
-
PO3-16: Altered mouse adipose tissue IGF-1 expression influences glucose controlTrost, J. / Alcaniz Rolli, J. / Brockmann, G. et al. | 2014
-
PO3-18: Lipopolysaccharide (LPS) treatment increased the protein levels of GKAP42 (42-kDa cGMP-dependent protein kinase anchoring protein) followed by inhibition of insulinmediated glucose transporter (GLUT) 4 translocation to the plasma membrane and glucose uptake in adipocytesYu, B. C. / Ando, Y. / Obata, Y. / Takenaka, A. / Chida, K. / Hakuno, F. / Takahashi, S. I. et al. | 2014
-
GP3-1: Growth hormone (GH) replacement has a beneficial effect on glycosylated haemoglobin (HbA1c) levels in adult patients with GH deficiency (GHD) enrolled in the NordiNet(R) International Outcome Study (IOS)Weber, M. M. / Tonnes Pedersen, B. / Pournara, E. / Christiansen, J. S. et al. | 2014
-
PO2-13: Human growth hormone and human prolactin possess autocrine roles in hepatocellular carcinomaZhang, M. / Kong, X. / Wu, Z. / Yan, Y. / Pandey, V. / Wu, W. / Lu, X. / Zhang, W. / Li, G. / Tan, S. et al. | 2014
-
OR4-5: IGF bioactivity in sera and pleural effusions from patients suspected of lung cancerEspelund, U. / Hjortebjerg, R. / Folkersen, B. / Rasmussen, T. R. / Oxvig, C. / Frystyk, J. et al. | 2014
-
OR6-1: Dicarba modification of insulin peptides results in lower mitogenic activity signaled via IGF-1R and IR than insulinOng, S. C. / van Lierop, B. / Delaine, C. / Andrikopoulos, S. / Robinson, A. / Forbes, B. et al. | 2014
-
OR8-7: Insulin like growth factor-II (IGF-II) regulates mitochondrial phenotype, metabolism and DNA content to prevent apoptosis and to increase energy production efficiency promoting a more aggressive and chemoresistant breast cancer diseaseRadhakrishnan, V. K. / DeLeon, D. et al. | 2014
-
GP2-1: IGF-I ameliorates hepatic fibrosis in mouse models of nonalcoholic steatohepatitis and cirrhosis via inhibiting the activity or hepatic stellate cellsNishizawa, H. / Iguchi, G. / Fukuoka, H. / Takahashi, M. / Suda, K. / Bando, H. / Matsumoto, R. / Takahashi, Y. et al. | 2014
-
GP2-4: Insulin-like growth factor binding protein (IGFBP)-1 and its RGD domain: favorable in vivo actions in glucose regulationHaywood, N. / Yuldasheva, N. / Aziz, A. / Smith, J. / Cordell, P. / Kearney, M. / Wheatcroft, S. et al. | 2014
-
PO3-6: Serum concentrations of IGF-I and IGF-II proceed in a reciprocal manner during a physiological cycle and maternal IGFBP-4 concentration was lower in pregnant than in not pregnant dairy heifers during early pregnancyMeyerholz, M. / Mense, K. / Linden, M. / Knaack, H. / Wirthgen, E. / Hoeflich, A. / Lietzau, M. / Richard, C. / Raliou, M. / Sandra, O. et al. | 2014
-
PO3-10: Constitutive IRS1 expression causes cell competition, leading to defect in myogenic differentiationHakuno, F. / Yoneyama, Y. / Ozoe, A. / Takahashi, S. I. et al. | 2014
-
GP1-5: Presurgical somatostatin analogue versus direct surgery for newly-diagnosed acromegaly patients: a systematic review and meta-analysis, assessing clinical evidence using the GRADE systemNunes, V. S. / Correa, J. M. / Puga, M. E. / Silva, E. M. / Boguszewski, C. L. et al. | 2014
-
GP3-6: Mixed effects PK/PD modelling of NNC0195-0092 - a noncovalent albumin binding growth hormone derivative in the hypophysectomised ratThygesen, P. / Agerso, H. / Fels, J. J. / Johansen, N. L. et al. | 2014
-
PO2-4: Pregnancy in acromegaly patients treated with pegvisomantVan der Lely, A. J. / Gomez, R. / Heissler, J. F. / Akerblad, A. C. / Jonsson, P. / Camacho-Hubner, C. / Koltowska-Haggstrom, M. et al. | 2014
-
PO2-7: Assessing the impact of storage flexibility on daily life for patients and caregivers taking/administering growth hormone (GH)Kappelgaard, A. M. / Metzinger, C. P. / Signer-Romero, K. / Schnabel, D. et al. | 2014
-
PO4-4: Cerebrospinal fluid and serum levels of growth hormone (GH), insulin-like-growth factor-I (IGF-1), insulin-like growth factor binding protein -3 (IGFBP-3) and ghrelin in patients with bacterial and tuberculous meningitisAkinci, A. / Gungor, S. / Yucel, G. / Ozerol, H. I. et al. | 2014
-
PO5-1: Clinical relevance of serum prolactin level in perimenopausal women with metabolic syndromePchelin, I. / Hudiakova, N. / Shishkin, A. et al. | 2014
-
SY1-3: Dosing and Monitoring GH treatment in children born SGALeger, J. et al. | 2014
-
OR1-4: Successful GH treatment for severe growth failure in pediatric patients with anorexia nervosaFjellestad-Paulsen, A. / Bargiacchi, A. / Doyen, C. / Raverdy, C. / Carel, J. C. / Le Heuzey, M. F. / Leger, J. et al. | 2014
-
OR2-3: The Cardin-Weintraub Motif present in IGFBP-2 is required for growth and function of the mouse brainSchindler, N. / Mayer, J. / Kirschstein, T. / Saenger, S. / Gimsa, U. / Brenmoehl, J. / Ohde, D. / Zeissler, A. / Russo, V. / Metzger, F. et al. | 2014
-
OR3-2: GH enhances spine density in amygdalar neuronsGisabella, B. / Brophy, J. / Goosens, K. A. et al. | 2014
-
OR7-5: Safety, tolerability, pharmacokinetics and pharmacodynamics of TV-1106, a new long-acting treatment for growth hormone deficiencyCohenBarack, O. / Sakov, A. / Rasamoelisolo, M. / Bassan, M. / Brown, K. / Spiegelstein, O. et al. | 2014
-
GP1-3: Role of growth hormone (GH) signaling pathways in the development of atherosclerosisIshikawa, M. / Toyomura, J. / Kuboki, K. / Morita, T. / Tominaga, N. / Hirose, T. / Minami, S. / Yoshino, G. et al. | 2014
-
PO2-10: Growth hormone treatment: case studies in Dr Soetomo HospitalRochmah, N. / Faizi, M. et al. | 2014
-
PO2-17: Soluble alpha-Klotho and vitamin D in acromegalyBolanowski, M. / Jawiarczyk-Przybylowska, A. / Kolackov, K. et al. | 2014
-
SY1-2: Dosing and Monitoring GH Treatment in GH Deficient ChildrenCohen, P. et al. | 2014
-
GP1-1: Growth hormone targets expression of specific lipolytic genes to promote lipolysis of white adipose tissueLaw, Y. Y. / Romero, C. / Radovick, S. et al. | 2014
-
GP1-2: Autocrine human growth hormone suppression of E-CADHERIN via p44/42 MAPK promotes epithelial-tomesenchymal transition (EMT) of colorectal carcinoma cellsWang, J. / Wu, Z. / Pandey, V. / Chen, Y. / Zhu, T. / Lobie, P. et al. | 2014
-
PO2-20: Safety evaluation of long-term recombinant growth hormone (rGH) treatment in paediatric patients: interim analysis of NordiNet(R) International Outcome Study (IOS)Savendahl, L. / Pournara, E. / Tonnes Pedersen, B. / Blankenstein, O. et al. | 2014
-
PO4-1: Alpha-fetoprotein at birth: an early marker of circulating IGF-I in preterm infantsKistner, A. / Hellgren, G. / Hansen Pupp, I. / Ley, D. / Lofqvist, C. / Hellstrom, A. et al. | 2014
-
SY1-5: Growth hormone replacement in adult growth hormone deficiency: long-term efficacy and safetyJohannsson, G. et al. | 2014
-
SY1-6: Growth hormone and sarcopenia - future aspectsThorner, M. et al. | 2014
-
OR1-1: GH treatment modulates mortality in adult onset GH deficiency and a discordant socio-economic status is apparentStochholm, K. / Berglund, A. / Gravholt, C. / Christiansen, J. S. et al. | 2014
-
OR2-1: Impaired mTORC1 activity up-regulates IGFBP-1 synthesis during dietary protein restrictionTakenaka, A. / Hino, M. / Takeuchi, K. / Takahashi, S. I. et al. | 2014
-
OR4-2: Growth hormone is a more potent growth stimulating hormone than IGF-I: clinical perspectiveLaron, Z. / Kauli, R. / Iluz, M. / Samuel, K. / Silbergeld, A. et al. | 2014
-
OR5-5: Autocrine hGH stimulated miRNA 96-182-183 cluster promotes epithelial-mesenchymal transition and invasion in breast cancerZhang, W. / Qian, P. / Zhang, X. / Zhang, M. / Wang, H. / Wu, M. / Kong, X. / Tan, S. / Ding, K. / Perry, J. K. et al. | 2014
-
PO3-5: Developing predictive determinants of IGF/INS targeted therapies in ovarian cancer patient tumors and primary tumorgraftsBecker, M. / Hou, X. / Haluska, P. et al. | 2014
-
PO3-7: Growth hormone addition to medium in HepG2 cell culture: influence on IGF-I and IGF-II productionKnaack, H. / Mense, K. / Piechotta, M. et al. | 2014
-
GP3-3: The diagnostic accuracy of pegvisomant-primed glucagon stimulation test (PV-GST) compared to insulin tolerance (ITT) and glucagon stimulation (GST) tests in evaluating adult growth hormone (GH) reserveYuen, K. C. J. / Frystyk, J. / Rhoads, S. A. / Legg, S. E. / Bidlingmaier, M. et al. | 2014
-
PO3-8: Understanding and targeting the IGFBP-3/IGFBP-3R system in obesity related disorders: IGFBP-3R agonists as preventive and therapeutic interventions for obesity-induced IR and T2DMCai, Q. / Oh, Y. et al. | 2014
-
PO2-25: Assessment of hydration based on bioelectrical impedance analysis (BIA) and arm muscle area (AMA) in treatment-naive adult patients with growth hormone deficiency (GHD)Jorgensen, J. O. L. / Tonnes Pedersen, B. / Pournara, E. / Hoybye, C. et al. | 2014
-
OR1-5: Short-term low dose GH therapy improves insulin sensitivity but does not affect cortisol metabolism and ectopic fat accumulation in GH deficient adultsYuen, K. C. J. / Frystyk, J. / Klopfenstein, B. J. / Rooney, W. D. / Purnell, J. Q. et al. | 2014
-
OR5-2: Rabbits are a suitable animal model for the pre-clinical development of growth hormone agonists and antagonistsBielohuby, M. / Zarkesh-Esfahani, S. H. / Manolopoulou, J. / Khorasgani, M. T. / Aghili, Z. S. / Wilkinson, I. R. / Ross, R. J. / Bidlingmaier, M. et al. | 2014
-
OR6-5: Sexual dimorphism of insulin like growth factor I in exerciseMunive Herrera, V. A. / Torres Aleman, I. et al. | 2014
-
PO3-1: Molecular, biochemical, histological, and phylogenetic characterizations of insulin-like peptides and insulin/insulinlike growth factor (IGF)-I receptors in rotifersOzaki, Y. / Kaneko, G. / Hakuno, F. / Takahashi, S. I. / Mark Welch, D. et al. | 2014
-
PO2-22: Usability and safety of FlexPro(R) PenMate(R), a growth hormone (GH) injection system, in patients, caregivers and healthcare professionalsWen, Y. / Korsholm, C. N. / Klinck, R. / Kappelgaard, A. M. et al. | 2014
-
PO4-8: Subclinical hypothyroidism is associated with low IGF-I levels and decreased growth velocityBellini, H. / Maciel, L. M. / Custodio, R. J. / Milani, S. S. / Paula, M. S. / Antonini, S. R. / Liberatori, R. D. / Martinelli, C. E. et al. | 2014
-
SY2-2: The IRS proteins: determinants of IGF-1R signaling and tumor metabolismShaw, L. / Landis, J. / Zhu, S. / Janusis, J. / Mercado-Matos, J. et al. | 2014
-
GP2-5: Hyperglycaemia induces chemo-resistance of breast cancer cells via regulating IGFBP-2/oestrogen receptor (ERa) interactions: role of ERa phosphorylationZeng, L. / Holly, J. M. / Arshad, A. / Bahl, A. / Hathwar, S. / Perks, C. M. et al. | 2014
-
PO2-21: Growth hormone deficiency amongst nasopharyngeal cancer survivorsRatnasingam, J. / Karim, N. / Paramasivam, S. / Ibrahim, L. / Lim, L. L. / Jalaludin, A. / Tan, A. / Vethakkan, S. / Chan, S. P. et al. | 2014
-
PO2-23: Growth and puberty of children with congenital isolated growth hormone deficiencySmuel, K. / Kauli, R. / Laron, Z. et al. | 2014